Why the study?
Active lipoprotein lipase is required to prevent hypertriglyceridemia, a risk factor for cardiovascular disease, but the exact structure of the active dimer was unclear.
The cryoEM structure of the active LPL dimer reveals a novel hydrophobic pore adjacent to the active site, providing structural insights into triglyceride hydrolysis and the mechanism of LPL mutations causing hypertriglyceridemia.
No immediate change to hypertriglyceridemia management; extends LPL structural insights for future therapeutic targeting.
Lipoprotein lipase (LPL) hydrolyzes triglycerides from circulating lipoproteins, releasing free fatty acids. Active LPL is needed to prevent hypertriglyceridemia, which is a risk factor for cardiovascular disease (CVD). Using cryogenic electron microscopy (cryoEM), we determined the structure of an active LPL dimer at 3.9 Å resolution. This structure reveals an open hydrophobic pore adjacent to the active site residues. Using modeling, we demonstrate that this pore can accommodate an acyl chain from a triglyceride. Known LPL mutations that lead to hypertriglyceridemia localize to the end of the pore and cause defective substrate hydrolysis. The pore may provide additional substrate specificity and/or allow unidirectional acyl chain release from LPL. This structure also revises previous models on how LPL dimerizes, revealing a C-terminal to C-terminal interface. We hypothesize that this active C-terminal to C-terminal conformation is adopted by LPL when associated with lipoproteins in capillaries.
No takes yet. Share an insight, caveat, or question.
Gunn et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: